Trailing or Forward: Pick Your Denominator
A price-to-earnings ratio is a share price divided by earnings per share, and the choice of EPS period changes everything. Trailing P/E uses the last four reported quarters, so it is fact but stale, often pricing in a downturn that has already ended. Forward P/E uses analyst estimates for the next twelve months, so it is timely but only as good as the forecasts, and sell-side analysts rarely model a bust before it arrives.
A worked example makes the gap concrete. A stock trading at 2,400 rupees with trailing EPS of 100 sits at 24 times earnings. If next-year EPS is forecast at 125, the forward multiple is 19.2. Where a stock trades between those two numbers tells you how much recovery the market already believes in.
Sector Norms Worth Memorizing
A multiple means nothing without its sector context. Indian private banks such as HDFC Bank and ICICI Bank have spent the past decade between 8 and 12 times forward earnings, and their price action tracks book value growth more than EPS anyway. IT services names like TCS and Infosys cluster at 20 to 30 times depending on growth guidance. Consumer staples are the expensive corner: Hindustan Unilever and Nestle India have held above 40 times for years because their earnings repeat through every cycle, and buyers pay up for repetition.
Cyclicals invert the logic. Steel, capital goods and commercial vehicle makers often look cheapest at 5 to 8 times precisely when EPS is peaking, and most expensive when profits sit at trough. A low P/E printed on peak earnings is a trap rather than a bargain, which is how first-time buyers of commodity stocks get caught every cycle.
Two more anchors complete the map. Indian generics pharma trades 20 to 28 times with American pricing risk built in, and public sector banks have spent long stretches below 6 times for reasons of ownership and return on equity. When a stock sits far outside its historical band, the question is what changed in the business, not whether the market is simply wrong.
Earnings Quality Traps
Before trusting any multiple, interrogate the E in the denominator. One-time gains from selling land or an associate stake can inflate EPS for a single year and collapse the apparent P/E. Watch for treasury income propping up a bank, deferred tax reversals, subsidy write-backs, and the year a company simply changes its depreciation policy and manufactures growth on paper.
Cross-check operating cash flow against reported profit across four or five years. If cumulative profit runs well ahead of cumulative cash generation, some of those earnings exist only in the accounts. Receivable days creeping from 60 to 120 tell the same story from another angle: sales booked faster than customers actually pay.
The PEG Refinement
Peter Lynch popularized dividing the P/E by expected earnings growth. A 30 times stock growing 30 percent annually scores a PEG of 1, historically fair value for a quality grower, below 1 is interesting, and above 2 is usually hope. The refinement fails on cyclicals, where growth mean-reverts instead of compounding, and on banks, where growth is capped by capital. Use it on structural growers only.
Putting It to Work on ChokInvest
ChokInvest charts let you overlay any stock against its own ten-year P/E band, which beats comparing a paint maker with a power utility every single time. Set platform alerts for multiple expansion beyond two standard deviations, then check whether the move is earnings-driven or price-driven before acting on it.
A practical workflow for ChokInvest account holders: screen for a gap above 20 percent between trailing and forward multiples, verify that gap against the cash flow statement, then demand a PEG under 1.5 for anything held above 25 times. The ratio never delivers a verdict on its own, but paired with clean accounts it shows what the crowd is paying and what you are being asked to believe in return.